Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Biodesix (BDSX) over the last 5 years, with Q3 2025 value amounting to -$1.16.

  • Biodesix's EPS (Weighted Average and Diluted) rose 1714.29% to -$1.16 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.96, marking a year-over-year increase of 33157.89%. This contributed to the annual value of -$0.33 for FY2024, which is 4847.98% up from last year.
  • Latest data reveals that Biodesix reported EPS (Weighted Average and Diluted) of -$1.16 as of Q3 2025, which was up 1714.29% from -$0.08 recorded in Q2 2025.
  • Biodesix's EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.06 during Q4 2024, with a 5-year trough of -$4.52 in Q2 2021.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$0.59, with a median of -$0.29 in 2022.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 9269.32% in 2022, then crashed by 90000.0% in 2024.
  • Quarter analysis of 5 years shows Biodesix's EPS (Weighted Average and Diluted) stood at -$0.49 in 2021, then skyrocketed by 32.65% to -$0.33 in 2022, then soared by 72.73% to -$0.09 in 2023, then rose by 28.01% to -$0.06 in 2024, then tumbled by 1690.47% to -$1.16 in 2025.
  • Its last three reported values are -$1.16 in Q3 2025, -$0.08 for Q2 2025, and -$0.08 during Q1 2025.